Clinical Trial Update: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease [Phase 1, Phase 2]

View source ↗

Summary

Trial update showing Phase 1/2 results for anakinra in neonatal-onset multisystem inflammatory disease, with the study terminated and results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Neurologic Cutaneous and Articular Syndrome

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Nervous System Malformations, Arthropathy, Neurogenic | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-12-01